131 related articles for article (PubMed ID: 26987143)
1. [DIAGNOSTICS AND TREATMENT OF MALIGNANT TUMOURS WITHOUT DETECTED PRIMARY SITE].
Vologdin AA; Babsky VI
Klin Med (Mosk); 2015; 93(11):64-70. PubMed ID: 26987143
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostics and therapy for neuroendocrine neoplasia of an unknown primary - a plea for open exploration].
Begum N; Hubold C; Buchmann I; Thorns C; Bouchard R; Lubienski A; Schlöricke E; Zimmermann M; Lehnert H; Bruch HP; Bürk CG
Zentralbl Chir; 2014 Jun; 139(3):284-91. PubMed ID: 23508839
[TBL] [Abstract][Full Text] [Related]
3. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin, referred to Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1979-98].
Klop WM; Balm AJ; Keus RB; Hilgers FJ; Tan IB
Ned Tijdschr Geneeskd; 2000 Jul; 144(28):1355-60. PubMed ID: 10923158
[TBL] [Abstract][Full Text] [Related]
5. [Clinical recommendations for diagnosis, treatment and monitoring of patients with cancer of unknown primary site].
Bišof V; Juretić A; Trivanović D; Dintinjana RD; Sarçević B; Jakić-Razumović J; Ban M; Bošković L; Mise B-; Bura M; Stančić-Rokotov D
Lijec Vjesn; 2015; 137(3-4):65-9. PubMed ID: 26065281
[TBL] [Abstract][Full Text] [Related]
6. [Ovarian metastasis of extragenital tumors at the Zurich University Gynecologic Clinic 1978-1990].
Perucchini D; Caduff R; Schär G; Fink D; Köchli OR
Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):351-6. PubMed ID: 8964449
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma of unknown primary (CUP).
Pavlidis N; Fizazi K
Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
[TBL] [Abstract][Full Text] [Related]
8. [Unknown primary tumour--diagnostic strategies and treatment].
Møller AK; Gundgaard MG; Petersen BL; Daugaard G
Ugeskr Laeger; 2008 Nov; 170(48):3946-9. PubMed ID: 19087733
[TBL] [Abstract][Full Text] [Related]
9. CUP Syndrome-Metastatic Malignancy with Unknown Primary Tumor.
Zaun G; Schuler M; Herrmann K; Tannapfel A
Dtsch Arztebl Int; 2018 Mar; 115(10):157-162. PubMed ID: 29587959
[TBL] [Abstract][Full Text] [Related]
10. From Biology to Diagnosis and Treatment: The Ariadne's Thread in Cancer of Unknown Primary.
Mathew BG; Aliyuda F; Taiwo D; Adekeye K; Agada G; Sanchez E; Ghose A; Rassy E; Boussios S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982662
[TBL] [Abstract][Full Text] [Related]
11. [CUP syndrome: are there advances?].
Moll R
Verh Dtsch Ges Pathol; 2005; 89():125-36. PubMed ID: 18035682
[TBL] [Abstract][Full Text] [Related]
12. [Carcinoma with unknown primary site: Morphological diagnosis].
Zhuravlev AS
Arkh Patol; 2019; 81(2):51-58. PubMed ID: 31006781
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
Alberti C
G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
[TBL] [Abstract][Full Text] [Related]
14. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
[TBL] [Abstract][Full Text] [Related]
15. [Cancer of unknown primary site-current status and future direction].
Ichikawa Y; Okamoto I; Nakagawa K
Gan To Kagaku Ryoho; 2009 Jun; 36(6):907-9. PubMed ID: 19542709
[TBL] [Abstract][Full Text] [Related]
16. Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets.
Kirsten F; Chi CH; Leary JA; Ng AB; Hedley DW; Tattersall MH
Q J Med; 1987 Feb; 62(238):143-61. PubMed ID: 3659256
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a gene expression tumour classifier for cancer of unknown primary.
Tothill RW; Shi F; Paiman L; Bedo J; Kowalczyk A; Mileshkin L; Buela E; Klupacs R; Bowtell D; Byron K
Pathology; 2015 Jan; 47(1):7-12. PubMed ID: 25485653
[TBL] [Abstract][Full Text] [Related]
18. 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary.
Losa F; Iglesias L; Pané M; Sanz J; Nieto B; Fusté V; de la Cruz-Merino L; Concha Á; Balañá C; Matías-Guiu X
Clin Transl Oncol; 2018 Nov; 20(11):1361-1372. PubMed ID: 29808414
[TBL] [Abstract][Full Text] [Related]
19. [CUP syndrome-diagnostics from the perspective of pathology].
Pauli C
Radiologie (Heidelb); 2023 May; 63(5):336-345. PubMed ID: 37079060
[TBL] [Abstract][Full Text] [Related]
20. Switching benchmarks in cancer of unknown primary: from autopsy to microarray.
Pentheroudakis G; Golfinopoulos V; Pavlidis N
Eur J Cancer; 2007 Sep; 43(14):2026-36. PubMed ID: 17698346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
